SAT-495-Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the US
Ming Yang(BD Biosciences (United States)), Anna S. Lok(University of Michigan), Neehar D. Parikh(University of Michigan), Huiying Rao(Peking University), Sherry Fu(A. Alfred Taubman Health Care Center), Elizabeth Wu(University of Michigan), Huixin Liu(Peking University), Ran Fei(Peking University), Andy Lin(University of Michigan), Bo Feng(Peking University), Lai Wei(Nanjing University of Finance and Economics)
Cited by 0
Related Papers
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
|Hepatology|2003|4.3k
Management of hepatitis B: 2000—Summary of a workshop
|Gastroenterology|2001|786
Management of hepatitis B
|Hepatology|2007|635
New progress in the pharmacology of protocatechuic acid: A compound ingested in daily foods and herbs frequently and heavily
|Pharmacological Research|2020|301
Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
|Journal of Experimental & Clinical Cancer Research|2015|271